104 related articles for article (PubMed ID: 30648067)
1. Adenocarcinoma of the Lung with Miliary Metastases and Primary Resistance Exon 20 Mutations.
Hsu F
Cureus; 2018 Oct; 10(10):e3533. PubMed ID: 30648067
[TBL] [Abstract][Full Text] [Related]
2. [Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review].
Li L; Zhou L; Zhang J
Zhongguo Fei Ai Za Zhi; 2019 Dec; 22(12):798-804. PubMed ID: 31874677
[TBL] [Abstract][Full Text] [Related]
3. Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.
Hsu F; Nichol A; Toriumi T; De Caluwe A
Acta Oncol; 2017 Sep; 56(9):1175-1180. PubMed ID: 28521651
[TBL] [Abstract][Full Text] [Related]
4. Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation.
Schaller A; Beau-Faller M; Mennecier B; Renaud-Picard B; Weingertner N; Massard G; Quoix E
Case Rep Oncol; 2014; 7(3):769-73. PubMed ID: 25722667
[TBL] [Abstract][Full Text] [Related]
5. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
Togashi Y; Masago K; Kubo T; Sakamori Y; Kim YH; Hatachi Y; Fukuhara A; Mio T; Togashi K; Mishima M
Cancer; 2011 Feb; 117(4):819-25. PubMed ID: 20886633
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
Chung C
J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
[TBL] [Abstract][Full Text] [Related]
7. [Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma].
Dumoulin J; Rozensztajn N; Paradis M; Sellier J; Abel A; Giraud P; Labrune S; Chinet T
Rev Mal Respir; 2016 Jan; 33(1):67-71. PubMed ID: 25794997
[TBL] [Abstract][Full Text] [Related]
8. [Impacts of EGFR 19 exon mutations on brain metastases in treatment-naïve patients with lung adenocarcinoma].
Wang WL; Li HW; Cao JZ; Zhang XQ; Song X; Jia SF; Jia HX
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):744-748. PubMed ID: 29061017
[No Abstract] [Full Text] [Related]
9. Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations.
Okuma Y; Kashima J; Watanabe K; Homma S
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1601-1611. PubMed ID: 29858682
[TBL] [Abstract][Full Text] [Related]
10. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.
Laack E; Simon R; Regier M; Andritzky B; Tennstedt P; Habermann C; Verth CZ; Thöm I; Grob T; Sauter G; Bokemeyer C
J Thorac Oncol; 2011 Jan; 6(1):199-202. PubMed ID: 21178715
[TBL] [Abstract][Full Text] [Related]
11. Miliary lung metastases from non-small cell lung cancer with Exon 20 insertion: A dismal prognostic entity: A case report.
Sekine A; Katano T; Oda T; Ikeda S; Iwasawa T; Satoh H; Kataoka T; Okudela K; Ogura T
Mol Clin Oncol; 2018 Dec; 9(6):673-676. PubMed ID: 30546900
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of EGFR mutations in cerebrospinal fluid from lung adenocarcinoma patients with brain metastases.
Yang H; Cai L; Zhang Y; Tan H; Deng Q; Zhao M; Xu X
J Mol Diagn; 2014 Sep; 16(5):558-563. PubMed ID: 24994671
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of lung adenocarcinomas with epidermal growth factor receptor mutations and miliary disseminated carcinomatosis.
Kim HJ; Kang SH; Chung HW; Lee JS; Kim SJ; Yoo KH; Lee KY
Thorac Cancer; 2015 Sep; 6(5):629-35. PubMed ID: 26445612
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases.
Ke SB; Qiu H; Chen JM; Shi W; Chen YS
Curr Med Sci; 2018 Dec; 38(6):1062-1068. PubMed ID: 30536070
[TBL] [Abstract][Full Text] [Related]
15. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features.
Sekine A; Kato T; Hagiwara E; Shinohara T; Komagata T; Iwasawa T; Satoh H; Tamura K; Kasamatsu T; Hayashihara K; Saito T; Takahashi H; Ogura T
Lung Cancer; 2012 Jul; 77(1):64-9. PubMed ID: 22335887
[TBL] [Abstract][Full Text] [Related]
16. Miliary lung metastases from ROS1-rearranged lung adenocarcinoma: A case report.
Otoshi R; Sekine A; Okudela K; Katano T; Asaoka M; Ikeda S; Baba T; Komatsu S; Hagiwara E; Takashi O
Mol Clin Oncol; 2020 Jul; 13(1):80-82. PubMed ID: 32454978
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
18. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
19. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
20. Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China.
Li H; Cao J; Zhang X; Song X; Wang W; Jia S; Li Z; Jia H; Cao X; Zhou W; Lian J; Han S; Yang W; Xi Y; Lian S; Jing H
Clin Exp Metastasis; 2017 Jan; 34(1):63-71. PubMed ID: 27888377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
